Additionally, two oncolytic adenoviruses, Ad5Δ24 and Ad5/3Δ24 armed with GM-CSF, effectively induced tumor- and virus-specific immunity, were well-tolerated and demonstrated clinical benefits in some patients with advanced refractory solid tumors. The gene discussed is CSF2; the disease is neoplasm.